Structure

Physi-Chem Properties

Molecular Weight:  344.09
Volume:  334.655
LogP:  2.449
LogD:  1.772
LogS:  -3.451
# Rotatable Bonds:  3
TPSA:  131.36
# H-Bond Aceptor:  7
# H-Bond Donor:  5
# Rings:  3
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.28
Synthetic Accessibility Score:  3.519
Fsp3:  0.167
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.234
MDCK Permeability:  4.936883215123089e-06
Pgp-inhibitor:  0.002
Pgp-substrate:  0.113
Human Intestinal Absorption (HIA):  0.362
20% Bioavailability (F20%):  0.853
30% Bioavailability (F30%):  0.996

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.007
Plasma Protein Binding (PPB):  91.18272399902344%
Volume Distribution (VD):  0.731
Pgp-substrate:  11.383410453796387%

ADMET: Metabolism

CYP1A2-inhibitor:  0.867
CYP1A2-substrate:  0.575
CYP2C19-inhibitor:  0.026
CYP2C19-substrate:  0.052
CYP2C9-inhibitor:  0.326
CYP2C9-substrate:  0.739
CYP2D6-inhibitor:  0.216
CYP2D6-substrate:  0.22
CYP3A4-inhibitor:  0.069
CYP3A4-substrate:  0.054

ADMET: Excretion

Clearance (CL):  6.569
Half-life (T1/2):  0.89

ADMET: Toxicity

hERG Blockers:  0.012
Human Hepatotoxicity (H-HT):  0.081
Drug-inuced Liver Injury (DILI):  0.827
AMES Toxicity:  0.45
Rat Oral Acute Toxicity:  0.087
Maximum Recommended Daily Dose:  0.907
Skin Sensitization:  0.933
Carcinogencity:  0.025
Eye Corrosion:  0.008
Eye Irritation:  0.916
Respiratory Toxicity:  0.151

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC329091

Natural Product ID:  NPC329091
Common Name*:   Hyperxanthone C
IUPAC Name:   2,3,6,8-tetrahydroxy-1-(2-hydroxy-3-methylbut-3-enyl)xanthen-9-one
Synonyms:   Hyperxanthone C
Standard InCHIKey:  GONMHOQVFDWXLV-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C18H16O7/c1-7(2)10(20)5-9-15-14(6-12(22)17(9)23)25-13-4-8(19)3-11(21)16(13)18(15)24/h3-4,6,10,19-23H,1,5H2,2H3
SMILES:  Oc1cc(O)c2c(c1)oc1c(c2=O)c(CC(C(=C)C)O)c(c(c1)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL484835
PubChem CID:   11302345
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones
                • [CHEMONTID:0003519] 8-prenylated xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11713 Hypericum scabrum Species Hypericaceae Eukaryota n.a. n.a. n.a. PMID[15568778]
NPO11713 Hypericum scabrum Species Hypericaceae Eukaryota n.a. Uzbekistan n.a. PMID[15568778]
NPO11713 Hypericum scabrum Species Hypericaceae Eukaryota n.a. n.a. n.a. PMID[27280968]
NPO11713 Hypericum scabrum Species Hypericaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens IC50 = 9300.0 ug.mL-1 PMID[531484]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 11200.0 ug.mL-1 PMID[531484]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC329091 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9733 High Similarity NPC89474
0.9671 High Similarity NPC241904
0.9671 High Similarity NPC300727
0.9669 High Similarity NPC67396
0.9613 High Similarity NPC7483
0.9613 High Similarity NPC475985
0.9608 High Similarity NPC476242
0.9605 High Similarity NPC274730
0.9605 High Similarity NPC142339
0.9605 High Similarity NPC24640
0.96 High Similarity NPC202157
0.9554 High Similarity NPC6588
0.9554 High Similarity NPC477154
0.9554 High Similarity NPC117854
0.9551 High Similarity NPC326520
0.9551 High Similarity NPC473286
0.9545 High Similarity NPC14353
0.9545 High Similarity NPC56085
0.9545 High Similarity NPC228785
0.9545 High Similarity NPC321399
0.9542 High Similarity NPC48208
0.9542 High Similarity NPC236796
0.9542 High Similarity NPC156057
0.9542 High Similarity NPC475267
0.9542 High Similarity NPC474836
0.9542 High Similarity NPC469584
0.9542 High Similarity NPC474208
0.9542 High Similarity NPC162869
0.9536 High Similarity NPC474843
0.949 High Similarity NPC170245
0.9484 High Similarity NPC61010
0.9484 High Similarity NPC32694
0.9484 High Similarity NPC40491
0.9484 High Similarity NPC474186
0.9484 High Similarity NPC278052
0.9481 High Similarity NPC100123
0.9481 High Similarity NPC85121
0.9481 High Similarity NPC210459
0.9477 High Similarity NPC235165
0.9477 High Similarity NPC255106
0.947 High Similarity NPC204515
0.9423 High Similarity NPC211107
0.9423 High Similarity NPC472964
0.9419 High Similarity NPC45146
0.9419 High Similarity NPC474287
0.9419 High Similarity NPC263449
0.9419 High Similarity NPC36217
0.9419 High Similarity NPC119224
0.9419 High Similarity NPC472902
0.9419 High Similarity NPC475886
0.9419 High Similarity NPC235018
0.9419 High Similarity NPC200746
0.9419 High Similarity NPC320359
0.9416 High Similarity NPC217677
0.9416 High Similarity NPC472910
0.9416 High Similarity NPC222814
0.9416 High Similarity NPC472913
0.9416 High Similarity NPC472914
0.9416 High Similarity NPC99597
0.9416 High Similarity NPC96167
0.9416 High Similarity NPC223787
0.9416 High Similarity NPC472911
0.9416 High Similarity NPC245758
0.9416 High Similarity NPC210084
0.9416 High Similarity NPC470402
0.9416 High Similarity NPC165977
0.9412 High Similarity NPC37392
0.9412 High Similarity NPC321779
0.9412 High Similarity NPC113906
0.9408 High Similarity NPC106976
0.9404 High Similarity NPC62042
0.9363 High Similarity NPC473313
0.9363 High Similarity NPC220313
0.9363 High Similarity NPC236132
0.9363 High Similarity NPC197168
0.9363 High Similarity NPC236521
0.9363 High Similarity NPC152659
0.9363 High Similarity NPC472278
0.9363 High Similarity NPC329669
0.9363 High Similarity NPC248638
0.9359 High Similarity NPC474187
0.9359 High Similarity NPC474351
0.9359 High Similarity NPC308992
0.9359 High Similarity NPC475883
0.9355 High Similarity NPC250214
0.9355 High Similarity NPC95936
0.9351 High Similarity NPC472916
0.9351 High Similarity NPC201837
0.9346 High Similarity NPC298692
0.9346 High Similarity NPC74924
0.9346 High Similarity NPC213896
0.9346 High Similarity NPC18727
0.9346 High Similarity NPC192083
0.9304 High Similarity NPC239752
0.9304 High Similarity NPC475888
0.9304 High Similarity NPC472450
0.9304 High Similarity NPC275780
0.9304 High Similarity NPC224280
0.9304 High Similarity NPC25361
0.9299 High Similarity NPC201800
0.9299 High Similarity NPC329760
0.9299 High Similarity NPC25152
0.9299 High Similarity NPC470694
0.9299 High Similarity NPC220912
0.9295 High Similarity NPC139036
0.9295 High Similarity NPC80375
0.9295 High Similarity NPC470183
0.929 High Similarity NPC36852
0.929 High Similarity NPC472598
0.929 High Similarity NPC474055
0.929 High Similarity NPC299520
0.929 High Similarity NPC129684
0.929 High Similarity NPC78225
0.929 High Similarity NPC262286
0.929 High Similarity NPC181960
0.9286 High Similarity NPC472909
0.9286 High Similarity NPC477503
0.9286 High Similarity NPC213622
0.9286 High Similarity NPC2928
0.9286 High Similarity NPC45849
0.9286 High Similarity NPC200761
0.9286 High Similarity NPC470327
0.9281 High Similarity NPC302950
0.9281 High Similarity NPC236637
0.9281 High Similarity NPC199100
0.9281 High Similarity NPC180234
0.9281 High Similarity NPC219582
0.9281 High Similarity NPC120537
0.9281 High Similarity NPC101996
0.9276 High Similarity NPC151473
0.9276 High Similarity NPC338131
0.9276 High Similarity NPC184136
0.9272 High Similarity NPC188679
0.9272 High Similarity NPC194856
0.9272 High Similarity NPC276930
0.9272 High Similarity NPC294852
0.9272 High Similarity NPC321011
0.9245 High Similarity NPC39091
0.9245 High Similarity NPC477517
0.9241 High Similarity NPC189473
0.9241 High Similarity NPC270837
0.9241 High Similarity NPC23298
0.9241 High Similarity NPC186686
0.9241 High Similarity NPC207690
0.9241 High Similarity NPC41301
0.9241 High Similarity NPC474240
0.9236 High Similarity NPC266314
0.9236 High Similarity NPC472275
0.9236 High Similarity NPC228383
0.9231 High Similarity NPC152904
0.9231 High Similarity NPC172770
0.9231 High Similarity NPC474290
0.9231 High Similarity NPC469658
0.9231 High Similarity NPC22192
0.9231 High Similarity NPC185258
0.9226 High Similarity NPC291878
0.9226 High Similarity NPC472626
0.9226 High Similarity NPC195796
0.9226 High Similarity NPC138243
0.9226 High Similarity NPC164427
0.9226 High Similarity NPC13858
0.9226 High Similarity NPC470328
0.9226 High Similarity NPC471500
0.9226 High Similarity NPC209614
0.9226 High Similarity NPC320825
0.9226 High Similarity NPC278778
0.9226 High Similarity NPC326037
0.9226 High Similarity NPC191146
0.9226 High Similarity NPC68093
0.9226 High Similarity NPC35038
0.9226 High Similarity NPC250922
0.9221 High Similarity NPC183878
0.9221 High Similarity NPC75279
0.9221 High Similarity NPC160951
0.9221 High Similarity NPC206238
0.9221 High Similarity NPC255350
0.9221 High Similarity NPC271779
0.9221 High Similarity NPC176775
0.9221 High Similarity NPC167091
0.9221 High Similarity NPC69394
0.9221 High Similarity NPC47781
0.9221 High Similarity NPC292214
0.9221 High Similarity NPC145379
0.9221 High Similarity NPC22519
0.9221 High Similarity NPC280937
0.9221 High Similarity NPC276409
0.9221 High Similarity NPC231018
0.9221 High Similarity NPC472915
0.9221 High Similarity NPC274327
0.9221 High Similarity NPC88645
0.9221 High Similarity NPC250822
0.9216 High Similarity NPC117579
0.9216 High Similarity NPC171010
0.9211 High Similarity NPC1612
0.9211 High Similarity NPC183959
0.9205 High Similarity NPC207729
0.9187 High Similarity NPC243877
0.9187 High Similarity NPC14662
0.9187 High Similarity NPC474024
0.9182 High Similarity NPC37183

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC329091 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9346 High Similarity NPD2393 Clinical (unspecified phase)
0.9281 High Similarity NPD1934 Approved
0.9221 High Similarity NPD2801 Approved
0.8944 High Similarity NPD6166 Phase 2
0.8944 High Similarity NPD6168 Clinical (unspecified phase)
0.8944 High Similarity NPD6167 Clinical (unspecified phase)
0.8882 High Similarity NPD1511 Approved
0.8766 High Similarity NPD1512 Approved
0.8742 High Similarity NPD4868 Clinical (unspecified phase)
0.8742 High Similarity NPD3882 Suspended
0.8727 High Similarity NPD7074 Phase 3
0.872 High Similarity NPD3818 Discontinued
0.8696 High Similarity NPD5494 Approved
0.8683 High Similarity NPD4338 Clinical (unspecified phase)
0.8667 High Similarity NPD7054 Approved
0.8614 High Similarity NPD7472 Approved
0.8609 High Similarity NPD1550 Clinical (unspecified phase)
0.8609 High Similarity NPD1552 Clinical (unspecified phase)
0.8563 High Similarity NPD6797 Phase 2
0.8554 High Similarity NPD5844 Phase 1
0.8553 High Similarity NPD1549 Phase 2
0.8544 High Similarity NPD4380 Phase 2
0.8528 High Similarity NPD6959 Discontinued
0.8512 High Similarity NPD7251 Discontinued
0.85 High Similarity NPD7819 Suspended
0.8462 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8457 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8447 Intermediate Similarity NPD3817 Phase 2
0.8385 Intermediate Similarity NPD1465 Phase 2
0.8364 Intermediate Similarity NPD6232 Discontinued
0.8353 Intermediate Similarity NPD7808 Phase 3
0.8344 Intermediate Similarity NPD7075 Discontinued
0.8343 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD7473 Discontinued
0.8301 Intermediate Similarity NPD2796 Approved
0.8272 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8235 Intermediate Similarity NPD1510 Phase 2
0.8221 Intermediate Similarity NPD5402 Approved
0.8194 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8118 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8113 Intermediate Similarity NPD2532 Approved
0.8113 Intermediate Similarity NPD2534 Approved
0.8113 Intermediate Similarity NPD2533 Approved
0.8098 Intermediate Similarity NPD6801 Discontinued
0.8092 Intermediate Similarity NPD943 Approved
0.8092 Intermediate Similarity NPD1240 Approved
0.8092 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8092 Intermediate Similarity NPD1613 Approved
0.805 Intermediate Similarity NPD6799 Approved
0.8037 Intermediate Similarity NPD7411 Suspended
0.8012 Intermediate Similarity NPD3749 Approved
0.8 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD1607 Approved
0.7977 Intermediate Similarity NPD6559 Discontinued
0.7975 Intermediate Similarity NPD3750 Approved
0.7975 Intermediate Similarity NPD6599 Discontinued
0.7953 Intermediate Similarity NPD3751 Discontinued
0.7929 Intermediate Similarity NPD3787 Discontinued
0.7922 Intermediate Similarity NPD230 Phase 1
0.7911 Intermediate Similarity NPD2800 Approved
0.7885 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7881 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7877 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.787 Intermediate Similarity NPD1247 Approved
0.7865 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD6234 Discontinued
0.7836 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7834 Intermediate Similarity NPD2935 Discontinued
0.7834 Intermediate Similarity NPD6100 Approved
0.7834 Intermediate Similarity NPD6099 Approved
0.7829 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD5403 Approved
0.7778 Intermediate Similarity NPD3027 Phase 3
0.7778 Intermediate Similarity NPD3926 Phase 2
0.7771 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD37 Approved
0.7765 Intermediate Similarity NPD7199 Phase 2
0.775 Intermediate Similarity NPD4628 Phase 3
0.7746 Intermediate Similarity NPD7228 Approved
0.7738 Intermediate Similarity NPD4966 Approved
0.7738 Intermediate Similarity NPD4967 Phase 2
0.7738 Intermediate Similarity NPD7768 Phase 2
0.7738 Intermediate Similarity NPD4965 Approved
0.7697 Intermediate Similarity NPD3226 Approved
0.7676 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7673 Intermediate Similarity NPD2346 Discontinued
0.7669 Intermediate Similarity NPD5401 Approved
0.7658 Intermediate Similarity NPD3748 Approved
0.7636 Intermediate Similarity NPD1653 Approved
0.7616 Intermediate Similarity NPD5710 Approved
0.7616 Intermediate Similarity NPD5711 Approved
0.7613 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.761 Intermediate Similarity NPD1551 Phase 2
0.7607 Intermediate Similarity NPD7390 Discontinued
0.7598 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD6190 Approved
0.7584 Intermediate Similarity NPD8312 Approved
0.7584 Intermediate Similarity NPD8313 Approved
0.7581 Intermediate Similarity NPD6781 Approved
0.7581 Intermediate Similarity NPD6778 Approved
0.7581 Intermediate Similarity NPD6782 Approved
0.7581 Intermediate Similarity NPD6777 Approved
0.7581 Intermediate Similarity NPD6779 Approved
0.7581 Intermediate Similarity NPD6780 Approved
0.7581 Intermediate Similarity NPD6776 Approved
0.7578 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7572 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD2344 Approved
0.7561 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7544 Intermediate Similarity NPD919 Approved
0.7531 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7528 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD4908 Phase 1
0.747 Intermediate Similarity NPD920 Approved
0.747 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD447 Suspended
0.746 Intermediate Similarity NPD7435 Discontinued
0.7459 Intermediate Similarity NPD8434 Phase 2
0.7459 Intermediate Similarity NPD8150 Discontinued
0.7456 Intermediate Similarity NPD6844 Discontinued
0.7455 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7448 Intermediate Similarity NPD8151 Discontinued
0.7438 Intermediate Similarity NPD2799 Discontinued
0.7423 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD6651 Approved
0.7419 Intermediate Similarity NPD2861 Phase 2
0.7416 Intermediate Similarity NPD5953 Discontinued
0.7405 Intermediate Similarity NPD4363 Phase 3
0.7405 Intermediate Similarity NPD4360 Phase 2
0.7401 Intermediate Similarity NPD7286 Phase 2
0.7389 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD2309 Approved
0.7374 Intermediate Similarity NPD7685 Pre-registration
0.7371 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD7783 Phase 2
0.7368 Intermediate Similarity NPD7698 Approved
0.7368 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD7696 Phase 3
0.7368 Intermediate Similarity NPD7697 Approved
0.7368 Intermediate Similarity NPD1610 Phase 2
0.7362 Intermediate Similarity NPD1243 Approved
0.7349 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD7870 Phase 2
0.733 Intermediate Similarity NPD7871 Phase 2
0.7329 Intermediate Similarity NPD7033 Discontinued
0.7325 Intermediate Similarity NPD4625 Phase 3
0.7316 Intermediate Similarity NPD6823 Phase 2
0.7314 Intermediate Similarity NPD7229 Phase 3
0.7312 Intermediate Similarity NPD6535 Approved
0.7312 Intermediate Similarity NPD6534 Approved
0.7308 Intermediate Similarity NPD9494 Approved
0.7306 Intermediate Similarity NPD7701 Phase 2
0.7289 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD2313 Discontinued
0.7278 Intermediate Similarity NPD7240 Approved
0.7256 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD1933 Approved
0.7231 Intermediate Similarity NPD7874 Approved
0.7231 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD9269 Phase 2
0.7196 Intermediate Similarity NPD7700 Phase 2
0.7196 Intermediate Similarity NPD7699 Phase 2
0.7194 Intermediate Similarity NPD7801 Approved
0.7193 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD1203 Approved
0.7179 Intermediate Similarity NPD1470 Approved
0.7175 Intermediate Similarity NPD5242 Approved
0.717 Intermediate Similarity NPD3268 Approved
0.717 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD5353 Approved
0.7161 Intermediate Similarity NPD4749 Approved
0.7161 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD6832 Phase 2
0.7143 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1201 Approved
0.7135 Intermediate Similarity NPD2403 Approved
0.7134 Intermediate Similarity NPD2798 Approved
0.7125 Intermediate Similarity NPD6233 Phase 2
0.711 Intermediate Similarity NPD5761 Phase 2
0.711 Intermediate Similarity NPD5760 Phase 2
0.7105 Intermediate Similarity NPD1548 Phase 1
0.7101 Intermediate Similarity NPD6273 Approved
0.7097 Intermediate Similarity NPD1608 Approved
0.7097 Intermediate Similarity NPD4287 Approved
0.7091 Intermediate Similarity NPD2424 Discontinued
0.709 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.709 Intermediate Similarity NPD4361 Phase 2
0.7088 Intermediate Similarity NPD3658 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD4060 Phase 1
0.7077 Intermediate Similarity NPD7584 Approved
0.7074 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7074 Intermediate Similarity NPD6212 Phase 3
0.7074 Intermediate Similarity NPD6213 Phase 3
0.707 Intermediate Similarity NPD2797 Approved
0.7069 Intermediate Similarity NPD4288 Approved
0.7063 Intermediate Similarity NPD1699 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data